Web Analytics

Start up Profile

Athernal Bio

Athernal Bio United Kingdom - Cambridge
START UP

1 Disclosed Funding Rounds $4,718,630
0 Participating Investments




Developing targeted immunotherapies to treat high-risk clonal haematopoiesis (CH)—the precursor to blood cancers—so we can stop cancer before it starts.

Capital Raised

Date Round Raised Participating Investors
October, 02 ,2025 Unknown $4,718,630